The pathophysiology of intestinal bacterial overgrowth syndromes.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000254:growth & development* / Q000378:metabolism; D018407:Bacterial Physiological Phenomena; D001647:Bile Acids and Salts / Q000502:physiology; D002446:Celiac Disease / Q000209:etiology; D006224:Cricetinae; D006168:Guinea Pigs; D006801:Humans; D007410:Intestinal Diseases / Q000209:etiology*; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000382:microbiology*; D007422:Intestines / Q000382:microbiology* / Q000503:physiopathology; D008286:Malabsorption Syndromes / Q000209:etiology; D013577:Syndrome
D000900:Anti-Bacterial Agents; D001647:Bile Acids and Salts